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Table S1. Lethal and Teratogenic Effects Observed in Zebrafish (Danio rerio) Embryos at Different 
Hours post Fertilization (hpf) 
 
aNo clear organs structure is recognized. 
bMalformation of eyes was recorded for the retardation in eye development and abnormality in shape 
and size. 
cPresence of none, one or more than two otoliths per sacculus, as well as reduction and enlargement 
of otoliths and/or sacculi (otic vesicles). 
dTail malformation was recorded when the tail was bent, twisted or shorter than to control embryos 
as assessed by optical comparation. 
eGrowth retardation was recorded by comparing with the control embryos in a body length (after 
hatching, at and onwards 72 hpf) using by optical comparation using an inverted microscope (CKX41; 




Category  Developmental endpoints Exposure time (hpf) 
   24 48 72 96 120 
        
Lethal effect Coagulated eggs ● ● ● ● ● 
  Lack of the heart beating ● ● ● ● ● 
Teratogenic effect Malformation of head ● ● ● ● ● 
  Malformation of eyes ● ● ● ● ● 
  Malformation of sacculi/otoliths ● ● ● ● ● 
  Malformation of chorda ● ● ● ● ● 
  Malformation of tail ● ● ● ● ● 
  Scoliosis ● ● ● ● ● 
  Yolk edema ● ● ● ● ● 
  Yolk deformation ● ● ● ● ● 
  Growth retardation   ● ● ● 
  Hatching    ● ● 
Cardiotoxicity  Pericardial edema   ● ● ● 
  Heart morphology    ● ● 




                      
 
Figure S1. Toxicity evaluation in the zebrafish model. The treated zebrafish embryos were followed 
for the survival and teratogenicity (A) as well as hepatotoxicity (B). Hepatotoxicity evaluation was 
performed in the transgenic Tg(fabp10:EGFP) zebrafish embryos with fluorescently labelled liver 
(green color), that were exposed to the tested compounds at 72 hpf onwards (the stage when the liver 
become vascularized and performed metabolic transformation of the absorbed compounds). At 120 
hpf stage, the embryos upon 10 µM of 4 had normally developed liver as those in the control (DMSO-
treated) group, while the embryos upon 10 µM of 5 showed darker liver with less green fluorescence 















































NMR spectra of synthesized compounds 
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